Chronic diarrhoea: causes, tests, treatment and supplement evidence

Chronic diarrhoea is an ongoing or recurrent loose-stool pattern lasting at least four weeks. It needs a cause-focused assessment: IBS is one possibility, but inflammation, coeliac disease, medicines, infection, microscopic colitis and other conditions can resemble it. Confidence: high that history, targeted tests and nutrition matter; variable for individual tests and treatments, and insufficient for a universal independent supplement verdict. This guide explains the diagnostic conversation rather than providing one regimen for every cause.

Table of contents

• Evidence summary
• What chronic diarrhoea is
• How it works
• The evidence-based treatments
• Supplement and lifestyle evidence
• What works and what does not
• Risks and side effects
• Important interactions
• Who needs special assessment
• Clinician-led treatment and use
• Animal and in-vitro evidence
• Funding and source roles
• Frequently asked questions
• Sources and funding notes

Evidence summary

Clinical guidance, human outcome research and funding independence answer different questions. The guidance below explains care; it does not independently reproduce the trials behind a medicine or supplement.

What chronic diarrhoea is

NIDDK defines chronic diarrhoea as symptoms lasting at least four weeks, whether continuous or recurring. A person can have clinically important symptoms without being ill every day. The usual stool pattern, the change from it and its effect on daily life should be described together. NIDDK definition.

This is a symptom category. It includes conditions affecting digestion, absorption, inflammation or bowel function. A diagnosis should explain why stools are loose and what follow-up is needed, rather than merely rename the symptom.

The chronic-diarrhoea discussion differs from uncomplicated short-term gastroenteritis. Repeatedly using a medicine intended to suppress a brief episode can leave an underlying problem unexplained. New bleeding, marked pain or dehydration still needs urgent assessment even when symptoms have been present for months.

How it works

Some causes prevent nutrients from being properly digested or absorbed; others involve intestinal inflammation or altered bowel function. Infections, food intolerance, coeliac disease, Crohn’s disease, ulcerative colitis, pancreatic problems, certain operations and medicines are among the possibilities described by NIDDK. NIDDK causes.

Bile acids can also contribute to persistent watery stools, particularly in some people with ileal disease or surgery. More than one condition may coexist. A familiar label such as IBS does not make a new change in the pattern irrelevant.

The 2018 British Society of Gastroenterology guideline highlights night-time or continuous symptoms and weight loss as reasons to consider an organic cause. It also warns that symptom criteria alone do not reliably exclude inflammation, microscopic colitis or bile acid diarrhoea. Original BSG diagnostic guideline.

The evidence-based treatments

Start with a clinical history and examination. A clinician may review weight, hydration, medicines, diet, family history, travel and previous conditions. Blood or stool testing is then selected to investigate the plausible causes and complications. NIDDK assessment.

For suspected IBS, the NHS describes selective blood testing for coeliac disease and stool testing for infection or inflammatory disease. There is no single diagnostic IBS test. Typical symptoms and an appropriate assessment can support a positive diagnosis without every patient needing hospital investigations. NHS IBS diagnostic care.

Coeliac testing usually uses blood tests and sometimes small-intestinal biopsies. Starting a gluten-free diet beforehand can change the results. Tell the team about any restriction already started and agree how testing should proceed; do not undertake a personal gluten challenge from an online guide. NIDDK coeliac testing.

Microscopic colitis is diagnosed using colon biopsies examined under a microscope. The colon may look normal during the procedure, so a reassuring visual examination is not automatically equivalent to excluding this condition. NIDDK biopsy diagnosis.

Treatment follows the identified cause. The care needed for an intolerance is different from that for inflammation, pancreatic insufficiency or persistent infection. Ask which findings establish the working diagnosis and what would prompt the team to reconsider it.

Supplement and lifestyle evidence

Preserve nutrition while investigating the cause. A structured food and symptom journal can help identify reproducible problems without removing many foods at once. NIDDK advises changes that improve symptoms while maintaining nutritional adequacy. NIDDK nutrition planning.

A breath test for lactose intolerance considers the response to a specified lactose drink and records symptoms as well as hydrogen measurements. The result needs interpretation in the clinical context; “malabsorption” on its own is not an explanation for every continuing complaint. NIDDK lactose assessment.

If pancreatic insufficiency is suspected, faecal elastase testing is one option. NIDDK advises a solid or semisolid sample; the team should explain whether a watery sample or other limitations affect interpretation. Blood tests may also look for nutritional consequences. NIDDK pancreatic testing.

Probiotic preparations are not interchangeable. No corporate efficacy study is used to recommend a product here, and all studies summarized in public education have not been financially cleared. This leaves an independent evidence gap rather than a universal cure claim. NCCIH limits and safety.

What works and what does not

The useful outcome is not just fewer bowel movements. It is adequate hydration and nutrition, less urgency, improved daily function and a plan that makes sense for the cause. Agree how these outcomes will be followed during treatment.

Tests answer different questions. A blood test for coeliac disease, colon biopsies and a pancreatic stool test do not replace one another. Ask what each requested test is intended to find and how the result would change care.

Bile acid testing requires a specific discussion. Older BSG guidance supports investigating it, while NICE’s 2021 assessment found uncertain evidence connecting SeHCAT testing with longer-term outcomes and cost effectiveness for routine expansion. Existing testing services and local practice can therefore differ. NICE committee discussion.

If symptoms continue after reassuring initial tests, return for review rather than assume either that nothing is wrong or that every invasive test is required. Describe what has changed and ask what the next decision depends on.

Risks and side effects

Blood in stool, an unexplained persistent bowel change, weight loss or marked tiredness should be assessed. These findings can occur in conditions other than cancer, but that is a reason to investigate rather than dismiss them. The NHS recommends clinical review of bowel-cancer symptoms and urgent review of bloody diarrhoea or black/dark-red stool. NHS bowel-change assessment.

Seek emergency care for heavy or continuous rectal bleeding, severe sudden pain, collapse, confusion, difficult waking or dehydration with shock features. Do not wait for a routine specialist appointment when the person is acutely deteriorating. NHS bleeding emergencies; NHS shock guidance.

Repeated fluid loss and malabsorption can cause complications. Weight loss and poor food intake should be part of the medical assessment, including when restrictive diets were begun to control symptoms. NIDDK complications.

Important interactions

Review prescription medicines, antacids, laxatives, nutrient products and recently started treatments with a clinician or pharmacist. NIDDK identifies medicines and supplement ingredients among possible contributors. Necessary treatment should be reviewed safely rather than stopped without a plan. NIDDK medicine-related causes.

Tell the testing service about prescribed treatment and food restrictions before changing them. Preparation instructions depend on the test. An internet rule about avoiding all medicines or fasting for every investigation can undermine assessment or create unnecessary risk.

If another condition requires fluid or dietary restrictions, ask how it changes the diarrhoea plan. Keep the full medication and illness picture visible rather than treating this as an isolated gut symptom.

Who needs special assessment

People with impaired immunity, older adults and those with a surgical or significant intestinal history may need a different diagnostic pathway. Recent antibiotics or travel should be highlighted early. A doctor uses these details to select infection testing and other investigations. NIDDK history-based assessment.

The BSG guideline discussed here applies to adults. It should not be used as a self-directed investigation plan for a child. Poor growth, feeding difficulty or continuing diarrhoea in a child requires an age-appropriate clinical and nutritional assessment.

Seriously ill or immunocompromised patients should obtain clinical advice before probiotics. NCCIH identifies greater potential for harm in these groups, including infection risk. NCCIH vulnerable-patient precautions.

Clinician-led treatment and use

Bring a concise timeline: when the change began, whether symptoms happen overnight, stool appearance, urgency, leakage, pain and any weight change. Record recent travel, operations, medicines and family history. These details are more useful than a long list of unconnected supplement attempts.

For each test, ask what it could establish, what a normal result would leave unresolved and whether the sample or preparation matters. Keep a copy of previous endoscopy and pathology reports if available, especially when it is unclear whether biopsies were obtained.

Agree a review point, the measures of improvement and the warning signs requiring earlier help. If a food trial is recommended, agree what is changed and how nutrition is preserved. If a medicine is recommended, confirm suitability and monitoring with the prescriber. This guide provides no personal regimen, dose or test-ordering protocol.

Animal and in-vitro evidence

Laboratory changes in microbial composition, bile-acid handling or intestinal permeability can suggest mechanisms. They cannot establish the diagnosis of a person’s chronic diarrhoea or demonstrate clinical recovery from a commercial supplement. Animal and test-tube findings do not contribute to a clinical benefit verdict here.

Funding and source roles

NIDDK and NHS sources provide education and care context, not a financial clearance of the trials behind all diagnostic or therapeutic choices. The original BSG paper declares no dedicated grant or competing interests, but does not fully identify internal development resources. NICE has public and fee income and a health-system assessment remit. These distinctions remain visible below.

Frequently asked questions

Does a normal colonoscopy exclude microscopic colitis? Visual appearance alone may not. The diagnosis depends on appropriate biopsies. NIDDK microscopic-colitis diagnosis.

Should I remove gluten before testing? Discuss testing first; restriction can change coeliac results. NIDDK testing precautions.

Do I need every test mentioned? No. The clinician selects investigations according to the pattern, risk factors and previous results.

Does chronic diarrhoea mean cancer? No. It has many causes, but unexplained bowel change and warning signs still need assessment. NHS symptom interpretation.

Sources and funding notes

The 2018 BSG original full paper was read through an original-paper PDF copy because the PMC landing page presented a browser challenge. It is older diagnostic context and not a current dosing authority. NIDDK topic dates range from 2018 to 2024 and NHS IBS/dehydration pages from 2025 to 2026. NICE 2021 SeHCAT committee text was read in indexed original-source retrieval; direct access was blocked. NICE statutory accounts provenance is institutional and does not certify its supporting studies. This guide does not provide a medicine or supplement efficacy ranking.

1. NIDDK: chronic category and complications — Duration, fluid loss and malabsorption; September 2024.
2. NIDDK: causes and warning signs — Broad differential and urgent assessment; September 2024.
3. NIDDK: diarrhoea diagnosis — Clinical history and selected investigations; September 2024.
4. NIDDK: diet and nutrition — Nutrition and organized symptom/food records; September 2024.
5. NIDDK: microscopic-colitis diagnosis — Normal-looking bowel can still require biopsies; April 2021.
6. NIDDK: coeliac diagnosis — Testing before gluten avoidance; October 2020.
7. NIDDK: pancreatic-insufficiency diagnosis — Faecal elastase sample quality and nutrition assessment; January 2023.
8. NIDDK: lactose diagnosis — Breath testing interpreted with symptoms; February 2018.
9. NHS: IBS diagnosis — Selective exclusion testing and positive clinical diagnosis; March 2025.
10. NHS: bowel-cancer symptoms — Persistent bowel change and bleeding assessment; current retrieved page.
11. NHS: dehydration — Dehydration and shock safety; May 2026.
12. NCCIH: probiotics — Product and high-risk safety uncertainty; no trial-level efficacy clearance.
13. BSG original chronic-diarrhoea guideline, 2018 — Limited diagnostic context; not current dosing, test-performance estimates or a drug efficacy verdict.
14. NICE SeHCAT assessment, 2021 / HTG598 — Indexed original committee discussion explains uncertainty about routine SeHCAT expansion; direct retrieval blocked.

Educational information reviewed 4 October 2026. This guide supports an informed clinical discussion; it does not diagnose an individual or provide a personal treatment regimen.